Zhu Shuchai,Dong Hui,Shen Wenbin,et al.The concurrent control study of elective nodal prophylactic irradiation with intensity modulated radiotherapy for esophageal carcinoma[J].Chinese Journal of Radiological Medicine and Protection,2014,34(10):758-762
The concurrent control study of elective nodal prophylactic irradiation with intensity modulated radiotherapy for esophageal carcinoma
Received:February 18, 2014  
DOI:10.3760/cma.j.issn.0254-5098.2014.10.009
KeyWords:Esophageal carcinoma  Radiotherapy  Elective nodal prophylactic irradiation  Involved-field irradiation  Concurrent control
FundProject:河北省医学适用技术跟踪项目(GL200848)
Author NameAffiliationE-mail
Zhu Shuchai Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China sczhu1965@163.com 
Dong Hui Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China  
Shen Wenbin Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China  
Liu Zhikun Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China  
Li Juan Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China  
Su Jingwei Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China  
Hits: 5299
Download times: 2468
Abstract::
      Objective: To explore the value of elective nodal prophylactic irradiation with intensity modulated radiotherapy(IMRT) for esophageal carcinoma. Screening patients who are suitable for elective nodal prophylactic irradiation (ENI), in order to improve locoregional control and overall survival. Methods: The concurrent control study was conducted to esophageal cancer patients who were treated by definitive radiotherapy. A total of 148 patients finished treatment were identified. Seventy-four patients received ENI, while the other seventy-four patients received involved-field irradiation (IFI). Kaplan-Meier method was used for calculation of locoregional control rates and overall survival rates. The univariate and multivariate analysis of prognostic factors were also tested. Results: The 1-, 3-, and 5- year locoregional control rates of ENI group and IFI group were 72.5%, 52.8%, 50.6% and 58.4%, 35.8%, 21.9% (χ2=7.881, P<0.05), respectively. The 1, 3, and 5 years survival rates of the ENI group and IFI group were 74.3%, 44.2%, 24.5% and 68.9%, 27.6%, 15.9% (χ2=1.903, P<0.05), respectively. In Cox multivariate analysis, clinical T stage, tumor location, different radiotherapy region were independent factors for the locoregional control of all patients, and clinical T, N stage, the length of esophageal barium meal and chemotherapy were independent factors for the overall survival of all patients. Conclusions: Esophageal carcinoma patients treated with ENI could achieve better locoregional control than those treated with IFI. Esophageal carcinoma patients with early stage or middle thoracic lesion could benefit from ENI for local control and overall survival.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:12029264  On-line:0

v
Scan QR Code
&et=950797345FA0C2472D3868BAAA648EB0835755F73A1FB72B411F67B5D6BE5E4A709EFB6646FF643BA479A9A22664DEC43FFA0BE56A56A2B2E2D423FECB166643459239BC6B68500DB95014BEA843A9227F8B95D326ECD89B3988AED85A58089659FC20BE5A58422337AE9D46145188545E93FAC67D1D271F26979DB7DD8C70389FB466D59AE5864F&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=9EAD63ADE6B277ED&aid=4E2DB2CDB9092F7D856F29E92005282F&vid=&iid=F3090AE9B60B7ED1&sid=3D8AB54CA690066A&eid=1CBB73E9593E8833&fileno=20141009&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="9EAD63ADE6B277ED"; var my_aid="4E2DB2CDB9092F7D856F29E92005282F";